Disruption in bone marrow fat may attenuate testosterone action on muscle size after spinal cord injury: a case report

Eur J Phys Rehabil Med. 2017 Aug;53(4):625-629. doi: 10.23736/S1973-9087.17.04452-5. Epub 2017 Mar 13.

Abstract

Background: Mesenchymal stem cells can be differentiated into muscle satellite cells. Testosterone replacement therapy (TRT) promotes the differentiation of satellite cells into muscle cells.

Case report: A 31-year-old male with a T4 complete chronic spinal cord injury (SCI) had fixation for a mid-shaft fracture of the left femur. The participant received transdermal testosterone patches (4 mg/day) daily for 16 weeks. Skeletal muscle and yellow bone marrow adiposity cross-sectional areas (CSAs) of both thighs were measured using magnetic resonance imaging.

Clinical rehabilitation impact: The yellow bone marrow CSA was 67-69% lower in the left femur compared to the right femur. Following intervention, a discrepancy was noted between the whole skeletal muscle CSAs of the right (+13%) and left (+6%) thighs. The right knee extensor CSA increased by 7% with no changes in the left CSA. Disruption in bone marrow fat may attenuate the systemic effects of TRT on muscle size.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adipose Tissue / metabolism*
  • Administration, Cutaneous
  • Adult
  • Bone Marrow / pathology
  • Femoral Fractures / diagnostic imaging
  • Femoral Fractures / surgery*
  • Follow-Up Studies
  • Fracture Fixation / methods
  • Fracture Fixation, Internal / methods
  • Humans
  • Male
  • Muscle, Skeletal / pathology*
  • Muscular Atrophy / physiopathology
  • Paraplegia / diagnosis
  • Paraplegia / rehabilitation
  • Spinal Cord Injuries / diagnostic imaging
  • Spinal Cord Injuries / rehabilitation*
  • Testosterone / therapeutic use*
  • Thoracic Vertebrae / injuries

Substances

  • Testosterone